News

A Cheshire business that aims to transform the UK’s self-care market has secured a £3.2m investment in a funding round led by Manchester-based Praetura Ventures. Maxwellia, which is based at Alderley Park, aims to give people easier a...

Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help progress its MET-X program which targets urinary tract infections caused by WHO critical-priority resistant Gram-negative bacteria. Pharmaron will manufacture the pat...

Independent clinical trial site management organisation (SMO), Panthera Biopartners, has appointed M&A and fundraisings adviser Chris Steed as a non-executive director. Chris has over 25 years’ experience as a corporate financier, w...

Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains. The COV-X program targets a protein which is essential for viral replication across a broad spectrum of related coronaviruses, including...

MANCHESTER, UK, 25th March 2021 - Healum, a leading digital health company, known for developing a ground-breaking AI powered patient management system to improve health outcomes and quality of life for people with long term conditions, has raised...